Vaccines Market Size, Share & Industry Analysis, By Type (Live Attenuated, Inactivated, Recombinant, mRNA Vaccine, Viral Vectors Vaccines, Toxoid), By Route of Administration (Parenteral & Oral), By Disease Indication (Viral Diseases {Hepatitis A, Hepatitis B, Polio, RSV, Influenza, HPV, Measles/Mumps/Rubella, Rotavirus, Shingles (Herpes Zoster)} & Bacterial Diseases {Pneumococcal Disease, Diphtheria, Meningococcal Disease}), By Age Group (Pediatric & Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers), & Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 10.5% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Type

• Live Attenuated
• Inactivated
• Recombinant/Conjugate/Subunit
• mRNA Vaccine
• Viral Vectors Vaccines
• Toxoid
• Others

By Route of Administration

• Parenteral
• Oral

By Disease Indication

• Viral Diseases
  • Hepatitis A
  • Hepatitis B
  • Polio
  • RSV
  • Influenza
  • HPV
  • Measles/Mumps/Rubella
  • Rotavirus
  • Shingles (Herpes Zoster)
  • Others
• Bacterial Diseases
  • Pneumococcal Diseases
  • Diphtheria/Tetanus/Pertussis
  • Meningococcal Diseases
  • Others
• Others

By Age Group

• Pediatric
• Adults

By Distribution Channel

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

By Region

• North America (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country)
  • U.S. (By Type)
  • Canada (By Type)
• Europe (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
  • U.K. (By Type)
  • Germany (By Type)
  • France (By Type)
  • Italy (By Type)
  • Spain (By Type)
  • Scandinavia (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
  • China (By Type)
  • Japan (By Type)
  • India (By Type)
  • Australia (By Type)
  • Southeast Asia (By Type)
  • Rest of Asia Pacific (By Type)
• Latin America (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, and Country/Sub-region)
  • GCC (By Type)
  • South Africa (By Type)
  • Rest of the Middle East & Africa (By Type)